JP2020521775A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020521775A5 JP2020521775A5 JP2019565535A JP2019565535A JP2020521775A5 JP 2020521775 A5 JP2020521775 A5 JP 2020521775A5 JP 2019565535 A JP2019565535 A JP 2019565535A JP 2019565535 A JP2019565535 A JP 2019565535A JP 2020521775 A5 JP2020521775 A5 JP 2020521775A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independently selected
- pharmaceutically acceptable
- unsubstituted
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *N(C1)CC1F Chemical compound *N(C1)CC1F 0.000 description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762513211P | 2017-05-31 | 2017-05-31 | |
| US62/513,211 | 2017-05-31 | ||
| US201762581919P | 2017-11-06 | 2017-11-06 | |
| US62/581,919 | 2017-11-06 | ||
| PCT/IB2018/053818 WO2018220531A1 (en) | 2017-05-31 | 2018-05-29 | 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020521775A JP2020521775A (ja) | 2020-07-27 |
| JP2020521775A5 true JP2020521775A5 (cg-RX-API-DMAC10.html) | 2021-07-26 |
| JP7187490B2 JP7187490B2 (ja) | 2022-12-12 |
Family
ID=62749123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565535A Expired - Fee Related JP7187490B2 (ja) | 2017-05-31 | 2018-05-29 | 寄生虫症の治療のための５，６－縮合二環式化合物及び組成物 |
Country Status (26)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190278A1 (ar) * | 2017-05-31 | 2019-11-28 | Novartis Ag | مركبات 5، 6-ثنائية الحلقة مندمجة وتركيبات لعلاج الأمراض الطفيلية |
| EP4136066A1 (en) * | 2020-04-17 | 2023-02-22 | DSM IP Assets B.V. | A process for preparation of substituted enamine compounds |
| CN113831320B (zh) * | 2020-06-23 | 2024-04-05 | 上海美悦生物科技发展有限公司 | 一种稠和吡唑类化合物的制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10053275A1 (de) * | 2000-10-27 | 2002-05-02 | Dresden Arzneimittel | Neue 7-Azaindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung |
| UA81453C2 (en) | 2003-02-27 | 2008-01-10 | Pyrazolopyridine derivates | |
| WO2012116246A2 (en) | 2011-02-25 | 2012-08-30 | Dow Agrosciences Llc | Pesticidal compostions and processes related thereto |
| WO2013067302A1 (en) | 2011-11-04 | 2013-05-10 | Glaxosmithkline Intellectual Property (No. 2) Limited | Method of treatment |
| WO2013106254A1 (en) | 2012-01-11 | 2013-07-18 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
| LT2925757T (lt) | 2012-11-19 | 2017-12-27 | Novartis Ag | Junginiai ir kompozicijos, skirti parazitinių ligų gydymui |
| UY35400A (es) | 2013-03-15 | 2014-10-31 | Novartis Ag | Compuestos y composiciones para el tratamiento de enfermedades parasitarias |
| US9186361B2 (en) | 2013-03-15 | 2015-11-17 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| JP6392352B2 (ja) * | 2013-12-19 | 2018-09-19 | ノバルティス アーゲー | リーシュマニア症などの寄生虫病を処置するための原生動物のプロテアソーム阻害剤としての［１，２，４］トリアゾロ［１，５−ａ］ピリミジン誘導体 |
| ES2700352T3 (es) | 2014-12-02 | 2019-02-15 | Bayer Cropscience Ag | Compuestos bicíclicos como pesticidas |
| CN107635984B (zh) | 2015-03-11 | 2021-04-13 | Fmc公司 | 杂环取代的二环唑杀有害生物剂 |
| AR104749A1 (es) * | 2015-05-29 | 2017-08-09 | Glaxosmithkline Ip Dev Ltd | Imidazo[1,2-b][1,2,4]triazina sustituida, composición farmacéutica y combinación que lo comprenden, y su uso para la fabricación de un medicamento |
| ES2856899T3 (es) * | 2015-08-07 | 2021-09-28 | Glaxosmithkline Ip Dev Ltd | Compuestos |
| CU24516B1 (es) | 2016-05-03 | 2021-05-12 | Bayer Pharma AG | Derivados aromáticos de sulfonamida útiles como medicamentos contra enfermedades asociadas con dolor |
| JOP20190278A1 (ar) * | 2017-05-31 | 2019-11-28 | Novartis Ag | مركبات 5، 6-ثنائية الحلقة مندمجة وتركيبات لعلاج الأمراض الطفيلية |
-
2017
- 2017-06-16 JO JOP/2019/0278A patent/JOP20190278A1/ar unknown
-
2018
- 2018-05-23 UY UY0001037745A patent/UY37745A/es not_active Application Discontinuation
- 2018-05-24 AR ARP180101377A patent/AR111826A1/es unknown
- 2018-05-29 JP JP2019565535A patent/JP7187490B2/ja not_active Expired - Fee Related
- 2018-05-29 CA CA3060990A patent/CA3060990A1/en active Pending
- 2018-05-29 CU CU2019000095A patent/CU24543B1/es unknown
- 2018-05-29 ES ES18734297T patent/ES2927207T3/es active Active
- 2018-05-29 AU AU2018276190A patent/AU2018276190B2/en not_active Ceased
- 2018-05-29 CR CR20190545A patent/CR20190545A/es unknown
- 2018-05-29 PE PE2019002477A patent/PE20201148A1/es unknown
- 2018-05-29 CN CN201880034658.0A patent/CN110678468B/zh not_active Expired - Fee Related
- 2018-05-29 RU RU2019138326A patent/RU2738647C1/ru active
- 2018-05-29 MA MA050495A patent/MA50495A/fr unknown
- 2018-05-29 WO PCT/IB2018/053818 patent/WO2018220531A1/en not_active Ceased
- 2018-05-29 EP EP18734297.7A patent/EP3630771B1/en active Active
- 2018-05-29 KR KR1020197034689A patent/KR20200010275A/ko not_active Withdrawn
- 2018-05-29 BR BR112019024804A patent/BR112019024804A2/pt not_active Application Discontinuation
- 2018-05-29 MX MX2019014321A patent/MX389106B/es unknown
- 2018-05-29 US US16/615,749 patent/US11384078B2/en not_active Expired - Fee Related
- 2018-05-29 TW TW107118305A patent/TW201902894A/zh unknown
-
2019
- 2019-11-25 PH PH12019502652A patent/PH12019502652A1/en unknown
- 2019-11-26 IL IL270927A patent/IL270927B/en unknown
- 2019-11-26 CO CONC2019/0013254A patent/CO2019013254A2/es unknown
- 2019-11-27 DO DO2019000299A patent/DOP2019000299A/es unknown
- 2019-11-27 CL CL2019003467A patent/CL2019003467A1/es unknown
- 2019-11-27 EC ECSENADI201984722A patent/ECSP19084722A/es unknown
-
2022
- 2022-05-13 US US17/744,432 patent/US20220324863A1/en not_active Abandoned